Piramal Pharma Ltd. Financials: Quarterly Results
Revenue
2183.11
Cr.
PAT
-146.45
Cr.
EBITDA
26.23
Cr.
Piramal Pharma Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 2139.87 | 2043.72 | 1933.71 | 2754.07 | 2204.22 |
| Total Income From Operations (Cr.) | 2139.87 | 2043.72 | 1933.71 | 2754.07 | 2204.22 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 26.23 | 21.45 | -32.18 | 360.26 | 153.06 |
| P/L Before Exceptional Items & Tax (Cr.) | -63.01 | -60.97 | -118.33 | 256.58 | 49.75 |
| P/L After Tax from Ordinary Activities (Cr.) | -146.45 | -114.01 | -100.27 | 137.28 | -13.37 |
| Net Profit/Loss For the Period (Cr.) | -146.45 | -114.01 | -100.27 | 137.28 | -13.37 |
| Basic EPS | -1.03 | -0.75 | -0.62 | 1.16 | 0.03 |
FAQs
Piramal Pharma Ltd. announced its quarterly results for Q3 FY2026 on January 29, 2026.
In Q3 FY2026, Piramal Pharma Ltd. are as follows:
Revenue: ₹2183.11 crore
Net Profit: ₹-146.45 crore.
For Q3 FY2026, Piramal Pharma Ltd. posted ₹2183.11 crore in revenue and ₹-146.45 crore in net profit.
Past quarterly results for Piramal Pharma Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.